Meet the judges

The panel of judges comprises recognised clinicians, GPs, nurses, pharmacists, commissioners and patient representatives working in the field of anticoagulation. 

2015 Judges include:

Frances commenced work in anticoagulation in 2002 with a PhD exploring the evidence-based redesign of anticoagulation services in different care settings. Over the years, Frances has redesigned and delivered a variety of anticoagulation service models in both secondary and primary care.  In her current role as consultant pharmacist for anticoagulation, Frances provides leadership through promoting clinical governance as it pertains to anticoagulation.

Sotiris is responsible for the development of cardiovascular prescribing guidelines across all of North East London as part of his role as consultant pharmacist.  He is an independent prescriber and is currently chair of the cardiac committee for United Kingdom Clinical Pharmacy Association (UKCPA).

He has published extensively in the pharmacy press and has a particular interest in improving anticoagulation for stroke prevention in atrial fibrillation.  Sotiris has been successful in obtaining a Darzi funded fellow to ‘co-design and test a new referral pathway for people with atrial fibrillation with community pharmacists’ with the aim to support individuals understanding of their condition and their therapy with the ultimate aim of optimising adherence.

He is actively involved in the training and development of clinical pharmacists including developing a curriculum and assessment tool for advanced and consultant level specialist cardiac pharmacists working with the UKCPA and Royal Pharmaceutical Society.   

Sotiris has served on many NICE development groups including Unstable Angina/NSTEMI guideline, stable angina and STEMI guidelines and is a current NICE TA member of the highly specialist technology appraisal group.  Sotiris is also an honorary senior research associate at UCL School of Pharmacy. 

Peter is a 68 year old metallurgical engineer and industrialist from Sheffield. He is a family man with children and grandchildren and still enjoys a busy working and social life. He is an active individual who still loves global travel and mountain trekking as his main hobbies.

During his thirties Peter was found to have a defective Aortic heart valve, possibly of hereditary origins. The gradually increasing effects of the heart valve problem were carefully monitored until in 1998 when Peter was 52 it was decided to replace the heart valve with a prosthetic implant at a hospital in Sheffield.

After 3 months convalescence Peter returned to his busy working life and eventually resumed his active hobbies of travel and mountain trekking which he still does today.

6 months after heart surgery Peter began to monitor his own INR and manage his own Anticoagulant dosage. As he gained experience he began to help and support others in similar situations through organisations such as AntiCoagulation Europe, assisted his local CCG and other medical bodies to formulate policies dealing with patient self-care and in 2014 was recruited by NICE to join their Diagnostic Advisory Committee producing new guidelines on patient self-monitoring of anticoagulation therapy.

Anna Burhouse is the Director of Quality for the West of England Academic Health Science Network. Anna leads on the Quality Improvement programmes, Evidence into Practice and Evidence into Commissioning and is supported by the Quality Improvement Team.

Anna is a Health Foundation Improvement Fellow, a Consultant Child and Adolescent Psychotherapist, an Ashridge Business School alumni and has 25 years’ experience of working in Health, Education and Social Care.

Throughout her career, Anna has specialised in roles which combine clinical and leadership skills to improve the quality and safety of services. Anna has been using quality improvement science in her work for the past twelve years, with a strong emphasis on the importance of service user and carer involvement in the co-production of services. Anna recently lead a Health Foundation Shine award “Coaching for Recovery” co-designing an educational approach to recovery for adults with long term health conditions and she is currently adapting this work to serve the needs of young people hoping to run the UK’s first Youth Recovery College in her spare time this autumn.

Professor Martin Cowie is Professor of Cardiology at the National Heart & Lung Institute, Imperial College, London, UK and Honorary Consultant Cardiologist at the Royal Brompton Hospital, London.

A founding member and a past-chairman of the British Society for Heart Failure, Professor Cowie has also been a Board member (and Chair of the Education Committee) of the Heart Failure Association of the European Society of Cardiology (ESC). He is the Specialty Advisor for Cardiovascular Interventions to the National Institute for Health and Care Excellence (NICE), and sat on its Acute Heart Failure Guideline Development Group and the Quality Standards Advisory Committee. He has helped advise on the patient decision aid for the updated NICE AF guideline,  published in June 2014. He is a member of the Cardiovascular Round Table and the EU Affairs Committee of the European Society of Cardiology. In 2015 he joined the Atrial Fibrillation Association’s Medical Advisory Committee.

Professor Cowie's studies and reviews have been featured in a variety of peer-reviewed journals, including The Lancet, British Medical Journal, JAMA, Circulation, European Heart Journal, Heart and the European Journal of Heart Failure. He has contributed chapters to many books, including the Oxford Textbook of Medicine, and has written a book for patients entitled ‘Living with Heart Failure – a guide for patients’. His research interests centre on health technology assessment, remote monitoring and new diagnostic and treatment approaches for patients with cardiovascular disease.

Sharron has 19 years’ experience working for the NHS, primarily within the hospital field as a specialist clinical pharmacist, in a variety of roles.  She also has nearly 7 years of expertise in a senior pharmacy management role which has supported the development of broad skills.

In her current role at HHFT she is a consultant anticoagulation pharmacist developing a Wessex wide project to improve anticoagulation in AF and develop anticoagulation practice at HHFT.  She co-chairs the UKCPA Haemostasis, anticoagulation and Thrombosis (HAT) committee.  She is VTE spokesperson for Royal Pharmaceutical Society & a member of the NHS VTE board.

Key achievements have been promoting the role of the pharmacist nationally, receiving an award for innovation from Lifeblood: the thrombosis charity and bravely stepping out to pharmacy management and back to a direct patient focussed role which she loves!

A Consultant Respiratory Physician specialising in the Pulmonary Circulation and Exercise Physiology. He runs a joint PE/Haematology Service at Hammersmith Hospital and has a particular clinical and research interest in the progression of pulmonary embolism to chronic thromboembolic pulmonary hypertension. He publishes and lectures internationally on the field of pulmonary embolism. He chairs the British Thoracic Society Guideline Group on Ambulatory Management of Pulmonary Embolism.

Joanne Malpas, Anticoagulant Services Manager, Haematology, Sandwell and West Birmingham Hospitals NHS Trust

Consultant Haematologist (Thrombosis and Haemostasis), King’s Thrombosis Centre London

Dr Patel is a Consultant Haematologist specialising in Haemostasis and Thrombosis. He trained in Haematology at King's, where he developed an interest in thrombotic liver disease and ethnicity. He works within the King’s Thrombosis Centre in London, and is responsible for Clinical Thrombosis Services and Medical Education. Interests include clinical trials, NOACs and anticoagulation pathway development for Primary Care. Dr Patel is a Training Programme Director for Haematology in London, and coordinates the International Training Scheme in Haematology at King’s.

Paula joined us from her role as Senior Account Manager at Pfizer, where she worked to identify opportunities to develop business with the NHS and generate improvements in service delivery. She has extensive commercial healthcare sector experience, including project management to support the redesign of a Plymouth community diabetes service.  As well as commercial experience, Paula has also spent time in the NHS in a clinical role, dealing with front line issues and patient services in both primary and secondary care settings

Paula said: ‘Industry is eager to help the NHS grow and to offer solutions but it’s crucial that NHS time and resources are spent on the most fruitful relationships. I come from both worlds and enjoy bringing them together so we can forge ahead together more rapidly.’

L.GB.03.2015.10437 March 2015


  • KEY DATES FOR 2017 TO BE ANNOUNCED
QiC Anticoagulation is supported by: